Dermata Therapeutics Stock Market Value
| DRMA Stock | USD 1.29 0.06 4.44% |
| Symbol | Dermata |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermata Therapeutics. Projected growth potential of Dermata fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Dermata Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Dermata Therapeutics's market price often diverges from its book value, the accounting figure shown on Dermata's balance sheet. Smart investors calculate Dermata Therapeutics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Dermata Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Dermata Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dermata Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Dermata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dermata Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dermata Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dermata Therapeutics.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Dermata Therapeutics on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Dermata Therapeutics or generate 0.0% return on investment in Dermata Therapeutics over 90 days. Dermata Therapeutics is related to or competes with Avenue Therapeutics, Psyence Biomedical, Lipella Pharmaceuticals, Virax Biolabs, Elevai Labs, GT Biopharma, and Revelation Biosciences. Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializ... More
Dermata Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dermata Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dermata Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 61.86 | |||
| Value At Risk | (16.23) | |||
| Potential Upside | 16.18 |
Dermata Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dermata Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dermata Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dermata Therapeutics historical prices to predict the future Dermata Therapeutics' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (0.32) |
Dermata Therapeutics February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.31) | |||
| Mean Deviation | 6.88 | |||
| Coefficient Of Variation | (1,091) | |||
| Standard Deviation | 9.96 | |||
| Variance | 99.16 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (1.10) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (0.32) | |||
| Maximum Drawdown | 61.86 | |||
| Value At Risk | (16.23) | |||
| Potential Upside | 16.18 | |||
| Skewness | 1.33 | |||
| Kurtosis | 4.64 |
Dermata Therapeutics Backtested Returns
Dermata Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0757, which denotes the company had a -0.0757 % return per unit of risk over the last 3 months. Dermata Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dermata Therapeutics' Variance of 99.16, mean deviation of 6.88, and Standard Deviation of 9.96 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.92, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dermata Therapeutics will likely underperform. At this point, Dermata Therapeutics has a negative expected return of -0.78%. Please make sure to confirm Dermata Therapeutics' rate of daily change, market facilitation index, as well as the relationship between the kurtosis and value at risk , to decide if Dermata Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.66 |
Good predictability
Dermata Therapeutics has good predictability. Overlapping area represents the amount of predictability between Dermata Therapeutics time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dermata Therapeutics price movement. The serial correlation of 0.66 indicates that around 66.0% of current Dermata Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.66 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dermata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dermata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dermata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dermata Therapeutics Stock:Check out Dermata Therapeutics Correlation, Dermata Therapeutics Volatility and Dermata Therapeutics Performance module to complement your research on Dermata Therapeutics. For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Dermata Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.